Katie Cunningham, Growth Marketing Manager, Author at EverGlade

Katie Cunningham, Growth Marketing Manager

Katie Cunningham, Growth Marketing Manager

DARPA Announces Protein Palace Proposers Day to Advance Universal Protein Purification

All Posts, DARPA, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA) wants to move protein purification beyond the “one protein, one ligand” model. Its upcoming Protein Palace program aims to develop a universal, tunable platform capable of rapidly purifying virtually any protein with high specificity, purity, and yield. The goal is to overcome a costly, time-consuming bottleneck that limits

DARPA Announces Protein Palace Proposers Day to Advance Universal Protein Purification Read More »

CBRN Medical Countermeasure PBA Opens a Pathway for Therapeutics, Diagnostics, and Development Partners

All Posts, CPE CBRND, Life Sciences / By

The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is inviting organizations to join its CBRN Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. The announcement seeks therapeutic developers, diagnostic innovators, and development support organizations to help accelerate the development, testing, and fielding of next-generation medical defense capabilities. The PBA establishes

CBRN Medical Countermeasure PBA Opens a Pathway for Therapeutics, Diagnostics, and Development Partners Read More »

BARDA Seeks SI-Enabled Ultrasound Devices for Point-of-Care Fracture Detection

All Posts, BARDA, Emerging Technologies, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has issued a Sources Sought Notice for Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection. The notice seeks information on commercially available and near-commercial technologies that could support rapid triage of fractures and soft tissue injuries in emergency departments, urgent care centers, and field settings. Responses are due

BARDA Seeks SI-Enabled Ultrasound Devices for Point-of-Care Fracture Detection Read More »

New RFI Seeks Prophylactic Platforms for Medical Countermeasure Development

All Posts, CPE CBRND, Life Sciences / By

The Portfolio Management Executive for Chemical, Biological, Radiological and Nuclear Defense (PME CBRND), through its Accelerated Defense Pharmaceuticals (ADP) program, has issued a Request for Information (RFI) on Prophylactic Platform Technologies for Medical Countermeasures. The government seeks input from commercial and academic product developers with platforms that could accelerate protection against priority chemical, biological, radiological,

New RFI Seeks Prophylactic Platforms for Medical Countermeasure Development Read More »

NSF X-Labs Funding Targets Bioengineering: From Protein Sequence to Function

All Posts, Life Sciences, NSF / By

The National Science Foundation (NSF) has announced From Sequence to Function, a new NSF X-Labs topic supporting platform technologies that connect protein sequence and structure to predictable, controllable biological function. Written proposals are due February 8, 2027, at 5:00 PM Eastern. NSF anticipates one or more Other Transaction (OT) awards under the topic. Issued through

NSF X-Labs Funding Targets Bioengineering: From Protein Sequence to Function Read More »

NIAID Releases 2027 Omnibus BAA for Vaccines, Therapeutics, and Diagnostics

All Posts, Life Sciences, NIAID / By

The National Institute of Allergy and Infectious Diseases (NIAID) has released its 2027 Division of Microbiology and Infectious Diseases (DMID) Omnibus Broad Agency Announcement (BAA) to advance medical interventions for infectious diseases. The solicitation covers three research areas: needle-free vaccines, therapeutic candidates, and in vitro diagnostic platforms. Full proposals for all three areas must be

NIAID Releases 2027 Omnibus BAA for Vaccines, Therapeutics, and Diagnostics Read More »

DARPA Releases Official HUBBLE Solicitation to Map Human Protein Interactions

All Posts, DARPA, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released the official solicitation for High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE). The program seeks computational capabilities to map human protein-protein interactions and identify new diagnostic and therapeutic targets for traumatic brain injury (TBI). Required abstracts are due

DARPA Releases Official HUBBLE Solicitation to Map Human Protein Interactions Read More »

Building a Virtual Cell Starts With Better Biological Data

All Posts, DOE, Emerging Technologies, Industry News, Life Sciences / By

On October 7, Biohub, The National Institutes of Health (NIH), and U.S. Department of Energy (DOE) announced a major expansion of an international effort to generate open, AI-ready data for predictive models of biology. The partners describe a $1.8 billion combination of funding, data, computation, and new measurement technology. The long-term goal is a virtual

Building a Virtual Cell Starts With Better Biological Data Read More »

FY2027 Federal Funding Choosing Where to Focus-Blog

The FY2027 Federal Funding Strategy Playbook: Webinar Recap

All Posts, Events, Industry News / By

Date: September 24, 2026 Hosted by: EverGlade and QNova LifeSciences Meet the Panelists Laura Powell, PhD, PMP, Director, Technical Team Lead, EverGlade Tyler Kessler, Director, Finance Team Lead, EverGlade Stephen Richardson, Head of Strategic Partnerships, EverGlade Jim Sergi, President and Founder, QNova LifeSciences Topics We Covered Federal agency activity and opportunities heading into FY2027 Consortia,

The FY2027 Federal Funding Strategy Playbook: Webinar Recap Read More »

BioMaP’s REDD Program Outlines a Path to Repurpose Equipment for Drug Delivery

All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through its BioMaP Consortium, has outlined a proposed development effort to turn stored manufacturing equipment into a platform for emergency drug delivery. The Repurposing Equipment for Drug Delivery (REDD) draft Statement of Objectives (SOO) calls for a recipient to relocate, restore, and repurpose specialized equipment originally designed to

BioMaP’s REDD Program Outlines a Path to Repurpose Equipment for Drug Delivery Read More »

DARPA APM Solicitation Opens for Programmable Precision Polymers

All Posts, DARPA, Defense, Life Sciences / By

The Defense Advanced Research Projects Agency’s (DARPA) Multi X Office has released the official solicitation for Atomically Precise Molecules (APM), seeking new polymer synthesis approaches that can deliver precisely controlled materials with breakthrough nonlinear optical performance. Required proposal abstracts are due October 27, 2026, at 1:00 p.m. ET, with full proposals due December 18, 2026,

DARPA APM Solicitation Opens for Programmable Precision Polymers Read More »

DOE Seeks Industry Input on Critical Mineral Recovery and Reuse

All Posts, DOE, Energy / By

The Department of Energy’s Office of Environmental Management (DOE-EM) is seeking industry input on recovering and repurposing surplus critical minerals and materials from its inventory. The Expression of Interest (EOI) explores potential collaborations that could strengthen domestic supply chains and support U.S. scientific, manufacturing, and energy needs. Responses are due November 2, 2026, with a virtual

DOE Seeks Industry Input on Critical Mineral Recovery and Reuse Read More »

Scroll to Top